Ullmann Wealth Partners Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Ullmann Wealth Partners Group's BMY Position: Q3 2026 in Review
Ullmann Wealth Partners Group opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 3,453 shares worth $215K. The stake represents 0.02% of the portfolio and ranks #170 among its holdings. This is a return to the name: Ullmann Wealth Partners Group previously reported a position in BMY as recently as Q2 2017.
Ullmann Wealth Partners Group first reported a position in BMY in Q1 2017 and has held it in 3 quarters since. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Ullmann Wealth Partners Group held 3,453 shares of Bristol-Myers Squibb worth $215K as of Q3 2026.
- Bristol-Myers Squibb was a new Ullmann Wealth Partners Group position in Q3 2026.
- Bristol-Myers Squibb made up 0.02% of Ullmann Wealth Partners Group's portfolio in Q3 2026, its #170 holding.
- Ullmann Wealth Partners Group first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 3 quarters since.
- 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Ullmann Wealth Partners Group's 13F filing for Q3 2026, filed 2 Nov 2026.